A Multiple Testing Procedure for Clinical Trials
1979/09/01 by Peter C. O'Brien, Peter C. O’Brien, Thomas R. Fleming · 56 citations
Mathematics · Decision Sciences · #Statistical Methods in Clinical Trials #Optimal Experimental Design Methods #Meta-analysis and systematic reviews
paper · doi:10.2307/2530245
Abstract
A multiple testing procedure is proposed for comparing two treatments when response to treatment is both dichotomous (i.e., success or failure) and immediate. The proposed test statistic for each test is the usual (Pearson) chi-square statistic based on all data collected to that point. The maximum number (N) of tests and the number (m1 + m2) of observations collected between successive tests is fixed in advance. The overall size of the procedure is shown to be controlled with virtually the same accuracy as the single sample chi-square test based on N(m1 + m2) observations. The power is also found to be virtually the same. However, by affording the opportunity to terminate early when one treatment performs markedly better than the other, the multiple testing procedure may eliminate the ethical dilemmas that often accompany clinical trials.
Citations
Cited by
- A Unifying Family of Group Sequential Test Designs
- A Group Sequential Test for Treatment Effect Based on the Fine–Gray Model
- Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery With High Risk for Postoperative Complications: Results of a Randomized Clinical Trial
- Group sequential clinical trial designs for composite endpoints incorporating recurrent and terminal events
- Time-uniform, nonparametric, nonasymptotic confidence sequences
- Sequential Control of False Positives in Online Change Point Detection
- A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study
- Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer
- Rapid Learning with Stochastic Focus of Attention
- Blinded‐Into‐Unblinded Interim Analyses for Clinical Trials With Time‐to‐Event Endpoints
- Sequential Tests of Multiple Hypotheses Controlling Type I and II Familywise Error Rates
- Detecting Rewards Deterioration in Episodic Reinforcement Learning
- Rapid evaluation and calibration of Bayesian group sequential designs via conjugate-mixture semi-simulation
- Sequential Testing for Assessing the Incremental Value of Biomarkers Under Biorepository Specimen Constraints with Robustness to Model Misspecification
- A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age
- Bayesian Sequentially Monitored Multi-arm Experiments with Multiple Comparison Adjustments
- TITE-Safety: Time-to-event Safety Monitoring for Clinical Trials
- Multiplicity Considerations in the Design and Analysis of Clinical Trials
- Biases in the Blind Spot: Detecting What LLMs Fail to Mention
- Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: A multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer
- Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges
- Past, present, and future of Phase 3 vaccine trial design: rethinking statistics for the 21st century
- A multi-stage drop-the-losers design for multi-arm clinical trials
- The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95
- Covariate-adjusted Group Sequential Comparisons of Restricted Mean Survival Times
- Adaptive clinical trial design with delayed treatment effects using elicited prior distributions
- An information metric for comparing and assessing informative interim decisions in sequential clinical trials
- Optimal scheduling of interim analyses in group sequential trials
- Efficient adaptive designs with mid-course sample size adjustment in\n clinical trials
- Multiplicity for a Group Sequential Trial with Biomarker Subpopulations
- Is Repeated Bayesian Interim Analysis Consequence-Free?
- Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial. [europepmc]
- Mediolateral oversizing influences pain, function, and flexion after TKA. [europepmc]
- International guidelines for bioequivalence of systemically available orally administered generic drug products: a survey of similarities and differences. [europepmc]
- The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. [europepmc]
- Development of the Serious Illness Care Program: a randomised controlled trial of a palliative care communication intervention. [europepmc]
- Adaptive designs undertaken in clinical research: a review of registered clinical trials. [europepmc]
- Neuroprotective potential of erythropoietin in neonates; design of a randomized trial. [europepmc]
- Trial Sequential Analysis in systematic reviews with meta-analysis. [europepmc]
- Key design considerations for adaptive clinical trials: a primer for clinicians. [europepmc]
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. [europepmc]
- Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. [europepmc]
- Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. [europepmc]
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. [europepmc]
- The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. [europepmc]
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial. [europepmc]
- Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs. [europepmc]
- Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. [europepmc]
- Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial. [europepmc]
- Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. [europepmc]
- Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial. [europepmc]
- Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. [europepmc]
- Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial. [europepmc]
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. [europepmc]
- Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial. [europepmc]
- Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury: The CRYOSTAT-2 Randomized Clinical Trial. [europepmc]
Related